The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Cyto Sorbents Appoints Peter J. Mariani As Chief Financial Officer
PUBLIC · CTSOAug 13, 2024•almost 2 years ago
Position
Chief Financial Officer
Company
CytoSorbents Corporation
Peter J. Mariani
PrincetonManufacturingBiotechnologyHealth Care
Description
CytoSorbents Corporation announces the retirement of Kathleen P. Bloch, the current Chief Financial Officer, and the appointment of Peter J. Mariani as the new Chief Financial Officer, effective August 14, 2024.
Company Information
Company
CytoSorbents Corporation
Location
Princeton, New Jersey, United States
About
CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.
CytoSorbents is a leader in the treatment of life-threatening conditions in the ICU and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is distributed in more than 70 countries and has CE Mark approval in the EU for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery.
PrincetonManufacturingBiotechnologyHealth Care